Opioids Market, by Drug Type (Codeine, Fentanyl, Morphine, Hydrocodone, Oxycodone, and Others), by Application (Analgesia, Cough Suppression, and Diarrhea Suppression), by Route of Administration (Oral, Topical, Parenteral, and Others), by Distribution Ch
Description
Opioids Market, by Drug Type (Codeine, Fentanyl, Morphine, Hydrocodone, Oxycodone, and Others), by Application (Analgesia, Cough Suppression, and Diarrhea Suppression), by Route of Administration (Oral, Topical, Parenteral, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
Opioids are a class of drugs which are largely used for relieving pain. One of the first opioid drugs ‘morphine’ was developed in 1803. Opioid drugs act on the opioid receptors present in the central and peripheral nervous system thus providing relief from pain. Opioid are administered in the form of as oral pills, parenteral, liquids, patches or lozenges. There are different types of prescription opioids available such as fentanyl, oxycodone, morphine, codeine, oxymorphone, and hydrocodone which are prescribed by physicians for treating pain.
Market Dynamics
Increasing R&D in synthesis of hybrids targeting opioid and neurokinin receptors is expected to offer lucrative growth opportunities for market players. For instance, in December 2019, researchers from Medical University of Lodz reported the synthesis, structure–activity relationship, and pharmacological characterization of a series of hybrids combining opioid pharmacophores with either substance P (SP) fragments or neurokinin receptor (NK1) antagonist fragments in order to comprehend the role of the neurokinin system in opioid-induced antinociception.
Key players in the market are focused on product approvals and launches to expand their product portfolio. For instance, in June 2018, AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company received the European Commission (EC) approval for DZUVEO for the management of acute moderate to severe pain in adults in medically monitored settings. The market is witnessing increasing merger and acquisition activities. For instance, Grünenthal acquired the U.S.-based pharmaceutical company ‘Averitas Pharma’ in order to expand its presence in the U.S.
Key features of the study:
This report provides an in-depth analysis of global opioids market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global opioids market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Johnson & Johnson, Endo International plc, Lupin Limited, Cadila Healthcare Limited, Purdue Pharma L.P., AbbVie Inc., Fresenius Kabi, Mallinckrodt Pharmaceuticals, Pfizer Inc., Rhodes Pharmaceuticals L.P., Sun Pharmaceutical Industries Limited, Nesher Pharmaceuticals (USA) LLC, Amneal Pharmaceuticals LLC, Trevena Inc., and Aurobindo Pharma Limited
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global opioids market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global opioids market
Detailed Segmentation:
Global Opioids Market, By Drug Type:
Codeine
Fentanyl
Morphine
Hydrocodone
Oxycodone
Others
Global Opioids Market, By Application:
Analgesia
Cough Suppression
Diarrhea Suppression
Global Opioids Market, By Route of Administration:
Oral
Topical
Parenteral
Others
Global Opioids Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Opioids Market, By Region:
North America
By Drug Type:
Codeine
Fentanyl
Morphine
Hydrocodone
Oxycodone
Others
By Application:
Analgesia
Cough Suppression
Diarrhea Suppression
By Route of Administration:
Oral
Topical
Parenteral
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
U.S.
Canada
Latin America
By Drug Type:
Codeine
Fentanyl
Morphine
Hydrocodone
Oxycodone
Others
By Application:
Analgesia
Cough Suppression
Diarrhea Suppression
By Route of Administration:
Oral
Topical
Parenteral
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Drug Type:
Codeine
Fentanyl
Morphine
Hydrocodone
Oxycodone
Others
By Application:
Analgesia
Cough Suppression
Diarrhea Suppression
By Route of Administration:
Oral
Topical
Parenteral
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
Asia Pacific
By Drug Type:
Codeine
Fentanyl
Morphine
Hydrocodone
Oxycodone
Others
By Application:
Analgesia
Cough Suppression
Diarrhea Suppression
By Route of Administration:
Oral
Topical
Parenteral
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Drug Type:
Codeine
Fentanyl
Morphine
Hydrocodone
Oxycodone
Others
By Application:
Analgesia
Cough Suppression
Diarrhea Suppression
By Route of Administration:
Oral
Topical
Parenteral
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
GCC
Israel
Rest of Middle East
Africa
By Drug Type:
Codeine
Fentanyl
Morphine
Hydrocodone
Oxycodone
Others
By Application:
Analgesia
Cough Suppression
Diarrhea Suppression
By Route of Administration:
Oral
Topical
Parenteral
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Teva Pharmaceutical Industries Ltd.*
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Johnson & Johnson
Endo International plc
Lupin Limited
Cadila Healthcare Limited
Purdue Pharma L.P.
AbbVie Inc.
Fresenius Kabi
Mallinckrodt Pharmaceuticals
Pfizer Inc.
Rhodes Pharmaceuticals L.P.
Sun Pharmaceutical Industries Limited
Nesher Pharmaceuticals (USA) LLC
Amneal Pharmaceuticals LLC
Trevena Inc.
Aurobindo Pharma Limited
“*” marked represents similar segmentation in other categories in the respective section.
Opioids are a class of drugs which are largely used for relieving pain. One of the first opioid drugs ‘morphine’ was developed in 1803. Opioid drugs act on the opioid receptors present in the central and peripheral nervous system thus providing relief from pain. Opioid are administered in the form of as oral pills, parenteral, liquids, patches or lozenges. There are different types of prescription opioids available such as fentanyl, oxycodone, morphine, codeine, oxymorphone, and hydrocodone which are prescribed by physicians for treating pain.
Market Dynamics
Increasing R&D in synthesis of hybrids targeting opioid and neurokinin receptors is expected to offer lucrative growth opportunities for market players. For instance, in December 2019, researchers from Medical University of Lodz reported the synthesis, structure–activity relationship, and pharmacological characterization of a series of hybrids combining opioid pharmacophores with either substance P (SP) fragments or neurokinin receptor (NK1) antagonist fragments in order to comprehend the role of the neurokinin system in opioid-induced antinociception.
Key players in the market are focused on product approvals and launches to expand their product portfolio. For instance, in June 2018, AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company received the European Commission (EC) approval for DZUVEO for the management of acute moderate to severe pain in adults in medically monitored settings. The market is witnessing increasing merger and acquisition activities. For instance, Grünenthal acquired the U.S.-based pharmaceutical company ‘Averitas Pharma’ in order to expand its presence in the U.S.
Key features of the study:
This report provides an in-depth analysis of global opioids market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global opioids market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Johnson & Johnson, Endo International plc, Lupin Limited, Cadila Healthcare Limited, Purdue Pharma L.P., AbbVie Inc., Fresenius Kabi, Mallinckrodt Pharmaceuticals, Pfizer Inc., Rhodes Pharmaceuticals L.P., Sun Pharmaceutical Industries Limited, Nesher Pharmaceuticals (USA) LLC, Amneal Pharmaceuticals LLC, Trevena Inc., and Aurobindo Pharma Limited
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global opioids market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global opioids market
Detailed Segmentation:
Global Opioids Market, By Drug Type:
Codeine
Fentanyl
Morphine
Hydrocodone
Oxycodone
Others
Global Opioids Market, By Application:
Analgesia
Cough Suppression
Diarrhea Suppression
Global Opioids Market, By Route of Administration:
Oral
Topical
Parenteral
Others
Global Opioids Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Opioids Market, By Region:
North America
By Drug Type:
Codeine
Fentanyl
Morphine
Hydrocodone
Oxycodone
Others
By Application:
Analgesia
Cough Suppression
Diarrhea Suppression
By Route of Administration:
Oral
Topical
Parenteral
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
U.S.
Canada
Latin America
By Drug Type:
Codeine
Fentanyl
Morphine
Hydrocodone
Oxycodone
Others
By Application:
Analgesia
Cough Suppression
Diarrhea Suppression
By Route of Administration:
Oral
Topical
Parenteral
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Drug Type:
Codeine
Fentanyl
Morphine
Hydrocodone
Oxycodone
Others
By Application:
Analgesia
Cough Suppression
Diarrhea Suppression
By Route of Administration:
Oral
Topical
Parenteral
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
Asia Pacific
By Drug Type:
Codeine
Fentanyl
Morphine
Hydrocodone
Oxycodone
Others
By Application:
Analgesia
Cough Suppression
Diarrhea Suppression
By Route of Administration:
Oral
Topical
Parenteral
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Drug Type:
Codeine
Fentanyl
Morphine
Hydrocodone
Oxycodone
Others
By Application:
Analgesia
Cough Suppression
Diarrhea Suppression
By Route of Administration:
Oral
Topical
Parenteral
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
GCC
Israel
Rest of Middle East
Africa
By Drug Type:
Codeine
Fentanyl
Morphine
Hydrocodone
Oxycodone
Others
By Application:
Analgesia
Cough Suppression
Diarrhea Suppression
By Route of Administration:
Oral
Topical
Parenteral
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Teva Pharmaceutical Industries Ltd.*
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Johnson & Johnson
Endo International plc
Lupin Limited
Cadila Healthcare Limited
Purdue Pharma L.P.
AbbVie Inc.
Fresenius Kabi
Mallinckrodt Pharmaceuticals
Pfizer Inc.
Rhodes Pharmaceuticals L.P.
Sun Pharmaceutical Industries Limited
Nesher Pharmaceuticals (USA) LLC
Amneal Pharmaceuticals LLC
Trevena Inc.
Aurobindo Pharma Limited
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
203 Pages
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Application
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Industry Trends
- Pricing Analysis
- Reimbursement Scenario
- Recent Product Approvals/Launches
- Regulatory Scenario
- PEST Analysis
- 4. COVID – 19 Impact Analysis
- COVID-19 Epidemiology
- Impact on Demand and Supply
- Impact on overall Healthcare Sector
- 5. Global Opioids Market, By Drug Type, 2017-2028 (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Codeine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Fentanyl
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Morphine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Hydrocodone
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Oxycodone
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- 6. Global Opioids Market, By Application, 2017 - 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Analgesia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Cough Suppression
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Diarrhea Suppression
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- 7. Global Opioids Market, By Route of Administration, 2017 - 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- 8. Global Opioids Market, By Distribution Channel, 2017 - 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- 9. Global Opioids Market, By Region, 2017 - 2028 (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2017 - 2028
- Regional Trends
- North America
- Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
- Market Size and Forecast, By Country/Region, 2017 - 2028 (US$ Mn)
- South Africa
- Central Africa
- North Africa
- 10. Competitive Landscape
- Company Profiles
- Teva Pharmaceutical Industries Ltd.*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Johnson & Johnson
- Endo International plc
- Lupin Limited
- Cadila Healthcare Limited
- Purdue Pharma L.P.
- AbbVie Inc.
- Fresenius Kabi
- Mallinckrodt Pharmaceuticals
- Pfizer Inc.
- Rhodes Pharmaceuticals L.P.
- Sun Pharmaceutical Industries Limited
- Nesher Pharmaceuticals (USA) LLC
- Amneal Pharmaceuticals LLC
- Trevena Inc.
- Aurobindo Pharma Limited
- *Key pointers provided are also applicable to other companies covered in the scope of the report.
- 11. Section
- Research Methodology
- About Us
- Contact
- *Browse 42 market data tables and 44 figures on "Opioids Market” - Global Forecast to 2028.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
